Elizabeth T. Birzin
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Estrogen and related hormone effects, Bioactive Compounds and Antitumor Agents, Receptor Mechanisms and Signaling, Neuroendocrine Tumor Research Advances, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Rapid Identification of Subtype-Selective Agonists of the Somatostatin Receptor Through Combinatorial Chemistry(1998)459 cited
- → Direct Agonist/Antagonist Functions of Dehydroepiandrosterone(2005)156 cited
- → 6H-Benzo[c]chromen-6-one derivatives as selective ERβ agonists(2006)144 cited
- → Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2(1998)128 cited
- → Estrogen Receptor Ligands. II. Discovery of Benzoxathiins as Potent, Selective Estrogen Receptor α Modulators(2004)99 cited
- → Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERα(2007)67 cited
- → Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers(2004)58 cited
- → Ivermectin Binding Sites in Sensitive and Resistant Haemonchus contortus(1994)56 cited
- → Spiro[1H-indene-1,4‘-piperidine] Derivatives As Potent and Selective Non-Peptide Human Somatostatin Receptor Subtype 2 (sst2) Agonists(1998)54 cited
- → Estrogen receptor ligands. Part 1: The discovery of flavanoids with subtype selectivity(2004)52 cited